DKL Dr.Kalebi Labs, DKL Drive Kalebi Labs, Real Towers Annex, Nairobi (2026)

13/08/2026

𝗪𝗵𝗲𝗻 𝗔𝗻𝘀𝘄𝗲𝗿𝘀 𝗠𝗮𝘁𝘁𝗲𝗿, 𝗗𝗡𝗔 𝗖𝗮𝗻 𝗣𝗿𝗼𝘃𝗶𝗱𝗲 𝗖𝗹𝗮𝗿𝗶𝘁𝘆.

Questions about biological relationships can arise for many reasons — personal, legal or even immigration-related. Whatever the circumstances, DNA testing requires accuracy, confidentiality and professional handling from collection to reporting.

At Dr. Kalebi Labs (DKL), our in-house DNA Paternity & Relationship Testing service provides reliable answers with a turnaround time of just 1–2 days, using a simple and painless cheek swab.

𝗢𝗻𝗲 𝘁𝗲𝘀𝘁. 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗻𝗲𝗲𝗱𝘀.

𝗣𝗲𝗮𝗰𝗲 𝗼𝗳 𝗠𝗶𝗻𝗱 𝗗𝗡𝗔 𝗧𝗲𝘀𝘁𝗶𝗻𝗴
For individuals and families seeking private confirmation of biological relationships and personal clarity.

𝗟𝗲𝗴𝗮𝗹 𝗗𝗡𝗔 𝗧𝗲𝘀𝘁𝗶𝗻𝗴
For cases where formally documented DNA evidence may be required, including custody, inheritance and other legal proceedings, with appropriate identity verification and chain-of-custody procedures.

𝗜𝗺𝗺𝗶𝗴𝗿𝗮𝘁𝗶𝗼𝗻 𝗗𝗡𝗔 𝗧𝗲𝘀𝘁𝗶𝗻𝗴
For biological relationship verification in immigration, visa and family reunification processes, subject to the requirements of the relevant embassy or immigration authority.

𝗪𝗵𝘆 𝗰𝗵𝗼𝗼𝘀𝗲 𝗗𝗞𝗟?

✔ Testing performed in-house at DKL
✔ Results in 1–2 days
✔ Simple, painless cheek swab collection
✔ Strict confidentiality and professional handling
✔ Legal chain-of-custody options available
✔ Accessible to individuals and families across Kenya

Because DNA testing is about more than obtaining a laboratory result. It is about providing an answer that may carry significant personal, family or legal importance — and ensuring that answer is handled with the professionalism and discretion it deserves.

At DKL, we combine advanced Human Identification (HID) technology with rigorous laboratory processes to provide fast, precise and confidential DNA relationship testing.

📍 Dr. Kalebi Labs (DKL)
Real Towers Annexe, Upper Hill, Nairobi
📲 +254 750 333 000 | +254 111 057 333

DKL — Proudly Kenyan. Innovative. Distributive. Disruptive. A New Era of Lab Services.

11/08/2026

Every diagnosis has a beginning

10/08/2026

𝗕𝗲𝘆𝗼𝗻𝗱 𝗔𝗟𝗧 & 𝗔𝗦𝗧: 𝗔 𝗖𝗹𝗼𝘀𝗲𝗿 𝗟𝗼𝗼𝗸 𝗮𝘁 𝗟𝗶𝘃𝗲𝗿 𝗜𝗻𝗷𝘂𝗿𝘆 𝘄𝗶𝘁𝗵 𝗚𝗟𝗗𝗛 𝗮𝘁 𝗗𝗞𝗟

𝙉𝙤𝙩 𝙖𝙡𝙡 𝙚𝙡𝙚𝙫𝙖𝙩𝙚𝙙 𝙡𝙞𝙫𝙚𝙧 𝙚𝙣𝙯𝙮𝙢𝙚𝙨 𝙩𝙚𝙡𝙡 𝙩𝙝𝙚 𝙨𝙖𝙢𝙚 𝙨𝙩𝙤𝙧𝙮.

ALT and AST remain important markers in evaluating liver health, but in complex clinical situations, additional specificity can provide valuable insight. This is where 𝗚𝗟𝗗𝗛 (𝗚𝗹𝘂𝘁𝗮𝗺𝗮𝘁𝗲 𝗗𝗲𝗵𝘆𝗱𝗿𝗼𝗴𝗲𝗻𝗮𝘀𝗲) adds value.

GLDH is a mitochondrial enzyme found predominantly in hepatocytes, making it a highly liver-specific biomarker of hepatocellular injury. Its measurement can complement conventional liver markers and provide clinicians with additional information when assessing the presence and extent of liver cell damage.

𝗪𝗵𝗲𝗿𝗲 𝗰𝗮𝗻 𝗚𝗟𝗗𝗛 𝗯𝗲 𝘃𝗮𝗹𝘂𝗮𝗯𝗹𝗲?

✔ Acute hepatocellular injury
✔ Drug- or toxin-induced liver injury
✔ Ischaemic liver injury
✔ Chronic liver disease assessment
✔ Significant hepatocellular damage or necrosis
✔ Complex cases where additional clarification of liver injury is required

At 𝗗𝗿. 𝗞𝗮𝗹𝗲𝗯𝗶 𝗟𝗮𝗯𝘀 (𝗗𝗞𝗟), GLDH is performed on our advanced 𝗥𝗼𝗰𝗵𝗲 𝗧𝗼𝘁𝗮𝗹 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗼𝗻 (𝗧𝗟𝗔) platform and is offered both as a standalone test and as part of our comprehensive Liver Function Test (LFT) panels.

⏱ 𝗧𝘂𝗿𝗻𝗮𝗿𝗼𝘂𝗻𝗱 𝗧𝗶𝗺𝗲: 𝟭 𝗛𝗼𝘂𝗿

By expanding liver assessment beyond conventional markers, DKL continues to give clinicians access to specialised diagnostics that support more informed clinical decision-making — with the speed, quality and reliability required in modern patient care.

📲 Access our services through the 𝗗𝗞𝗟 𝗔𝗽𝗽 — request tests, track samples and securely receive results.

📍 Real Towers Annexe, Upper Hill, Nairobi
📞 +254 111 057 333 / 4 / 5
📞 +254 750 333 000 | +254 769 333 000
📧 [email protected]

08/08/2026

𝗗𝗞𝗟 𝗪𝗲𝗹𝗰𝗼𝗺𝗲𝘀 𝗞𝗲𝗻𝘆𝗮𝗻 𝗦𝗽𝗿𝗶𝗻𝘁 𝗦𝘁𝗮𝗿 𝗙𝗲𝗿𝗱𝗶𝗻𝗮𝗻𝗱 𝗢𝗺𝗮𝗻𝘆𝗮𝗹𝗮 🇰🇪

Yesterday, we had the pleasure of welcoming 𝗙𝗲𝗿𝗱𝗶𝗻𝗮𝗻𝗱 𝗢𝗺𝗮𝗻𝘆𝗮𝗹𝗮 to Dr. Kalebi Labs (DKL) for a comprehensive laboratory health check-up at our state-of-the-art national referral laboratory.

Omanyala was warmly received by our dedicated DKL team, who took him through his check-up while giving him a firsthand experience of our advanced laboratory technologies, streamlined systems and patient-centred services.

We were delighted by his appreciation of the experience and the level of service, technology and professionalism in place at DKL.

Regular health check-ups are an important part of proactive healthcare. They provide valuable insights into key health indicators, help establish individual health baselines and can support early identification of changes that may require further attention. For athletes whose bodies operate at exceptionally high levels of performance, access to comprehensive and reliable laboratory diagnostics is equally important in supporting informed health and wellness decisions.

Omanyala is one of Kenya and Africa’s most accomplished sprinters and the 𝗔𝗳𝗿𝗶𝗰𝗮𝗻 𝟭𝟬𝟬𝗺 𝗿𝗲𝗰𝗼𝗿𝗱 𝗵𝗼𝗹𝗱𝗲𝗿, with a personal best of 𝟵.𝟳𝟳 seconds. He is a Commonwealth Games 100m champion and a multiple African champion who has represented Kenya at the highest levels of international athletics.

It was an honour to host him at DKL. We thank 𝗙𝗲𝗿𝗱𝗶𝗻𝗮𝗻𝗱 𝗢𝗺𝗮𝗻𝘆𝗮𝗹𝗮 for choosing and trusting DKL with his laboratory health check-up and wish him continued success in the journey ahead.

𝗔𝘁 𝗗𝗞𝗟, 𝘄𝗲 𝗯𝗲𝗹𝗶𝗲𝘃𝗲 𝗴𝗿𝗲𝗮𝘁 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗯𝗲𝗴𝗶𝗻𝘀 𝘄𝗶𝘁𝗵 𝗸𝗻𝗼𝘄𝗶𝗻𝗴 𝘆𝗼𝘂𝗿 𝗵𝗲𝗮𝗹𝘁𝗵.

08/08/2026

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗟𝗲𝘂𝗸𝗮𝗲𝗺𝗶𝗮 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝘄𝗶𝘁𝗵 𝗪𝗼𝗿𝗹𝗱-𝗖𝗹𝗮𝘀𝘀 𝗙𝗹𝗼𝘄 𝗖𝘆𝘁𝗼𝗺𝗲𝘁𝗿𝘆 — 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝘂𝗻𝗱𝗲𝗿 𝘁𝗵𝗲 𝗦𝗛𝗔 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗣𝗮𝗰𝗸𝗮𝗴𝗲

At Dr. Kalebi Labs (DKL), we are committed to providing patients and clinicians with advanced cancer diagnostics that enable timely diagnosis, accurate disease classification, and informed treatment decisions.

Our Flow Cytometry service, covered under the SHA Oncology (Cancer) Benefits Package, is performed using the Beckman Coulter DxFLEX Flow Cytometer with ClearLLab™️ 10-colour technology, delivering rapid, standardized immunophenotyping for the diagnosis and classification of leukaemia, lymphoma, and other haematological malignancies.

The service is performed entirely in-house using peripheral blood, bone marrow aspirates, fine-needle aspirates (FNA), and other body fluid specimens, ensuring fast turnaround times and reliable, high-quality results.

Our Flow Cytometry portfolio includes:

🩸 Acute Leukaemia Screening
🩸 Acute Lymphoblastic Leukaemia (ALL) & Acute Myeloid Leukaemia (AML) Panels
🩸 Chronic Lymphocytic Leukaemia (CLL) & T-Cell Lymphoid Panels
🩸 Myelodysplastic Syndromes (MDS) & Myeloproliferative Neoplasms (MPN) Panels
🩸 Specialized Panels for Acute Undifferentiated and Myelomonocytic Leukaemias

Supported by ISO 15189:2022 accreditation, rigorous quality assurance systems, and expert interpretation by experienced pathologists and laboratory specialists, our Flow Cytometry service delivers the precision and confidence clinicians need for optimal patient management.

By combining world-class technology with clinical expertise, DKL continues to make advanced oncology diagnostics more accessible through the SHA Oncology Benefits Package, helping improve outcomes for patients across Kenya.

Dr. Kalebi Labs — Delivering Precision Diagnostics for Better Cancer Care.

📍 Real Towers Annexe, Upper Hill, Nairobi
📞 24-Hour Call Centre

06/08/2026

𝗜𝗟-𝟲 (𝗜𝗻𝘁𝗲𝗿𝗹𝗲𝘂𝗸𝗶𝗻-𝟲) 𝗮𝘁 𝗗𝗞𝗟 – 𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗕𝗲𝘆𝗼𝗻𝗱 𝗧𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗼𝗿𝘆 𝗠𝗮𝗿𝗸𝗲𝗿𝘀 (𝗖𝗥𝗣, 𝗣𝗿𝗼𝗰𝗮𝗹𝗰𝗶𝘁𝗼𝗻𝗶𝗻 & 𝗙𝗲𝗿𝗿𝗶𝘁𝗶𝗻): 𝗔𝗻 𝗘𝗮𝗿𝗹𝗶𝗲𝗿, 𝗙𝗮𝘀𝘁𝗲𝗿, 𝗦𝗺𝗮𝗿𝘁𝗲𝗿 & 𝗠𝗼𝗿𝗲 𝗔𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗔𝗱𝗷𝘂𝗻𝗰𝘁 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗳𝗼𝗿 𝗦𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻, 𝗦𝗲𝗽𝘀𝗶𝘀, 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝘃𝗲 𝗧𝗶𝘀𝘀𝘂𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗮𝗻𝗱 𝗢𝘁𝗵𝗲𝗿 𝗛𝘆𝗽𝗲𝗿𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗼𝗿𝘆 𝗦𝘁𝗮𝘁𝗲𝘀

Most clinicians routinely request CRP when assessing inflammation. However, IL-6 is one of the principal cytokines that initiates the inflammatory response by stimulating the liver to produce CRP and other acute-phase proteins.

Simply put: IL-6 rises first. CRP follows.

Because IL-6 increases within 1–3 hours, it provides an earlier and more direct indication of active systemic inflammation, helping clinicians detect disease sooner, assess severity, stratify risk and monitor treatment response in near real time.

Comparison of inflammatory biomarkers

• IL-6: Rises in 1–3 hours; earliest marker, reflects disease severity and declines rapidly with effective treatment.
• Procalcitonin: Rises in 3–6 hours; particularly useful in bacterial infections.
• CRP: Rises in 6–12 hours; excellent for monitoring but follows IL-6.
• Ferritin & ESR: Rise later and often remain elevated despite clinical improvement.

Think of IL-6 as the fire and CRP as the smoke. Measuring IL-6 offers an earlier window into the inflammatory process, enabling faster diagnosis and more informed clinical decisions.

IL-6 provides the greatest clinical value when used alongside other biomarkers:

• IL-6 + CRP: Earlier detection and follow-up monitoring.
• IL-6 + Procalcitonin: Better assessment of bacterial versus non-bacterial inflammation.
• IL-6 + Ferritin: Enhanced evaluation of cytokine storm syndromes, HLH/MAS and other hyperinflammatory conditions.

At Dr. Kalebi Labs (DKL), Roche Elecsys® Interleukin-6 (IL-6) has been available in-house since our inception, making DKL the first laboratory in Kenya to routinely offer this advanced biomarker on a high-throughput automated platform.

𝗧𝗲𝘀𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝘀

🧪 Method: Roche Elecsys® IL-6 (ECLIA) on the Roche cobas e801 platform
🩸 Specimen: Serum (preferred); lithium heparin or EDTA plasma
⏱️ Turnaround Time: Approximately 1 hour (assay time ~18 minutes)
🏥 Available 24/7

Our IL-6 assay is performed under DKL's ISO 15189-accredited Quality Management System, supported by CAP Proficiency Testing and External Quality Assessment (EQA).

Earlier detection. Dynamic monitoring. Smarter clinical decisions. Better patient outcomes.

DKL – A New Era of Laboratory Services.

06/08/2026

𝗗𝗿. 𝗞𝗮𝗹𝗲𝗯𝗶 𝗟𝗮𝗯𝘀 (𝗗𝗞𝗟) 𝗛𝗼𝘀𝘁𝘀 𝗔𝗳𝗿𝗶𝗰𝗮𝗻 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗲𝗻𝘁𝗿𝗲 𝗼𝗳 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 (𝗔𝗠𝗖𝗘), 𝗡𝗶𝗴𝗲𝗿𝗶𝗮, 𝗳𝗼𝗿 𝗮 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗕𝗲𝗻𝗰𝗵𝗺𝗮𝗿𝗸𝗶𝗻𝗴 𝗩𝗶𝘀𝗶𝘁

We were honoured to welcome a distinguished delegation from the 𝗔𝗳𝗿𝗶𝗰𝗮𝗻 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗲𝗻𝘁𝗿𝗲 𝗼𝗳 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 (𝗔𝗠𝗖𝗘), 𝗔𝗯𝘂𝗷𝗮, 𝗡𝗶𝗴𝗲𝗿𝗶𝗮, accompanied by the 𝗥𝗼𝗰𝗵𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀, team, to Dr. Kalebi Labs (DKL) for a strategic benchmarking visit focused on laboratory excellence, innovation, quality systems, and operational best practices.

The delegation was warmly received by our 𝗙𝗼𝘂𝗻𝗱𝗲𝗿, 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗖𝗵𝗮𝗶𝗿𝗺𝗮𝗻, 𝗖𝗘𝗢 & 𝗣𝗿𝗶𝗻𝗰𝗶𝗽𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝗶𝘀𝘁, 𝗗𝗿. 𝗔𝗵𝗺𝗲𝗱 𝗞𝗮𝗹𝗲𝗯𝗶, who led the engagement alongside members of the DKL leadership and technical teams.

During the comprehensive tour of our state-of-the-art national referral laboratory, the visitors experienced firsthand DKL's fully automated and paperless laboratory workflow, integrated digital systems, advanced diagnostic technologies, rigorous quality management processes, and patient-centred service delivery model. The discussions also explored laboratory operations, automation, digital transformation, workflow optimisation, quality assurance, and strategies for delivering timely, reliable, and world-class diagnostic services.

The visit concluded with an engaging roundtable discussion where both teams exchanged valuable insights, experiences, and ideas aimed at strengthening laboratory medicine across Africa through collaboration, continuous learning, and innovation.

We sincerely appreciate the opportunity to host this esteemed delegation and look forward to fostering stronger partnerships that advance diagnostic excellence and improve patient care across the continent.

𝗧𝗵𝗲 𝘃𝗶𝘀𝗶𝘁𝗶𝗻𝗴 𝗱𝗲𝗹𝗲𝗴𝗮𝘁𝗶𝗼𝗻 𝗶𝗻𝗰𝗹𝘂𝗱𝗲𝗱:

𝗔𝗳𝗿𝗶𝗰𝗮𝗻 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗲𝗻𝘁𝗿𝗲 𝗼𝗳 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 (𝗔𝗠𝗖𝗘), 𝗔𝗯𝘂𝗷𝗮, 𝗡𝗶𝗴𝗲𝗿𝗶𝗮
• Dr. Anshul Govilla – Chief Operations Officer
• Frank Oliyide – Director of Laboratory Operations
• Dr. Dokedensi Uya – Chemical Pathologist
• Emmanuel Ekoh – Laboratory Manager
• Greatfreeman Daniel – Business Manager

𝗥𝗼𝗰𝗵𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀
• Edwin Kibet – Regional Manager, Kenya & Mauritius
• Boniface Mathendu – Product Manager, Oncology
• Mubarak Gyedu – Head of Sales, Diagnostics & Near Patient Care, Nigeria
• Ivy Syovata – Key Account Manager, Diagnostics

Together, we continue to strengthen healthcare through knowledge sharing, strategic partnerships, and a shared commitment to advancing laboratory medicine across Africa.

04/08/2026

𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗡𝗔 & 𝗘𝗡𝗔 𝗣𝗿𝗼𝗳𝗶𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗼𝗻 𝘁𝗵𝗲 𝗘𝗨𝗥𝗢𝗜𝗠𝗠𝗨𝗡 𝗘𝗨𝗥𝗢𝗕𝗹𝗼𝘁𝗢𝗻𝗲 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗮𝘁 𝗗𝗞𝗟

Why does your DKL ANA & ENA Profile report show signal intensity instead of the traditional ANA titre?

The answer lies in the testing technology.

Traditional ANA testing using HEp-2 Indirect Immunofluorescence (ANA-IFA) reports an endpoint titre (e.g. 1:160 or 1:640) based on serial dilution of the patient’s serum. At DKL, we perform ANA & ENA Profile testing using the fully automated EUROIMMUN EUROBlotOne platform, which uses a standardised fixed-dilution multiplex immunoblot assay.

Instead of reporting an ANA titre, the system measures the signal intensity of each specific autoantibody through advanced digital image analysis. A stronger signal generally indicates a higher level of that specific antibody, but signal intensity is not equivalent to an ANA titre and should not be interpreted as one.

A major advantage of this technology is its ability to identify multiple clinically important autoantibodies in a single test, including SSA/Ro, Ro52, SSB/La, Sm, RNP, Scl-70, Jo-1, Centromere B, Mi-2, Histone, Ribosomal P, DFS70 and others associated with autoimmune connective tissue diseases such as SLE, Sjögren’s Syndrome, Systemic Sclerosis, Polymyositis/Dermatomyositis, and Mixed Connective Tissue Disease (MCTD).

At DKL, every test benefits from:
✅ ISO 15189:2022 Accredited Quality Management System
✅ CAP External Quality Assessment (EQA) participation
✅ Automated, objective software-based interpretation
✅ Same-day turnaround time for ANA & ENA Profile results

Laboratory findings should always be interpreted together with the patient’s clinical history, examination findings, and other relevant investigations.

📞 WhatsApp: 0750 333 000
📧 [email protected]

04/08/2026

𝗔 𝗪𝗮𝗿𝗺 𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝗗𝗿. 𝗞𝗮𝗹𝗲𝗯𝗶 𝗟𝗮𝗯𝘀 (𝗗𝗞𝗟)

We were delighted to welcome 𝗠𝗿. 𝗔𝗻𝘆𝗼𝗻𝗮 𝗘𝗿𝗶𝗰𝗸 𝗢𝗻𝗸𝗼𝗯𝗮, Human Resource Officer at the 𝘛𝘝𝘌𝘛 𝘊𝘶𝘳𝘳𝘪𝘤𝘶𝘭𝘶𝘮 𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵, 𝘈𝘴𝘴𝘦𝘴𝘴𝘮𝘦𝘯𝘵 𝘢𝘯𝘥 𝘊𝘦𝘳𝘵𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘊𝘰𝘶𝘯𝘤𝘪𝘭 (𝘛𝘝𝘌𝘛 𝘊𝘋𝘈𝘊𝘊), to Dr. Kalebi Labs (DKL) for his comprehensive health check-up.

Mr. Onkoba was warmly received by our Principal Pathologist, 𝗗𝗿. 𝗔𝗵𝗺𝗲𝗱 𝗞𝗮𝗹𝗲𝗯𝗶, and was accompanied by 𝗠𝗼𝘀𝗲𝘀 𝗢𝗻𝗱𝗶𝗲𝗸𝗶, Founder of the 𝘙𝘰𝘢𝘮𝘪𝘯𝘨 𝘗𝘩𝘭𝘦𝘣𝘰𝘵𝘰𝘮𝘺 & 𝘞𝘦𝘭𝘭𝘯𝘦𝘴𝘴 𝘊𝘦𝘯𝘵𝘳𝘦 (𝘙𝘗𝘞𝘊).

During his visit, Mr. Onkoba experienced DKL’s patient-centred approach to healthcare, where quality, efficiency, and convenience are at the heart of every service. He expressed his appreciation for the seamless care provided and was particularly impressed by the ease with which patients can securely access their laboratory results through the My DKL App—anytime, anywhere—bringing healthcare closer to patients and eliminating unnecessary return visits.

At DKL, we are committed to delivering accurate, timely, and innovative diagnostic services while continually enhancing the patient experience through technology and exceptional service.

We thank Mr. Onkoba for choosing DKL for his healthcare needs and wish him continued good health

03/08/2026

𝗜𝗻𝘀𝘁𝗮𝗻𝘁 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗦𝗺𝗮𝗿𝘁𝗲𝗿 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 — 𝗧𝗵𝗲 𝗗𝗞𝗟 𝗧𝗲𝘀𝘁 𝗠𝗲𝗻𝘂 📱💻

At Dr. Kalebi Labs (DKL), we’ve simplified how you access laboratory information. Our dynamic 𝗗𝗞𝗟 𝗧𝗲𝘀𝘁 𝗠𝗲𝗻𝘂, available on both our website and mobile app, puts thousands of diagnostic tests right at your fingertips — anytime, anywhere.

🔎 𝗜𝗻 𝘀𝗲𝗰𝗼𝗻𝗱𝘀, 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗮𝗰𝗰𝗲𝘀𝘀:

✅ Clear, detailed test descriptions
💰 Transparent upfront pricing
⏱️ Accurate turnaround times (TAT)
🧪 Specific sample requirements
🏠 Flexible options — walk in or book Home Sample Collection

Whether you’re a clinician making informed decisions, a patient tracking your health, or a facility referring samples, DKL ensures you have the right information before the test is even done.

𝗛𝗼𝗺𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗹𝗹𝗲𝗰𝘁𝗶𝗼𝗻? Book seamlessly via the app or website and let our professional team come to you.

Your health decisions deserve clarity, speed, and confidence.

🌐 Visit: http://dkl.co.ke
📱 Download the DKL App today (Google Play & App Store — search DKL Dr. Kalebi Labs)

DKL Dr.Kalebi Labs

13/08/2026

11/08/2026

10/08/2026

08/08/2026

08/08/2026

06/08/2026

06/08/2026

04/08/2026

04/08/2026

03/08/2026

Address

Website

Alerts

Shortcuts

Share

Category

Listing takedown request